Silo Pharma (SILO) Divestments (2019 - 2021)
Silo Pharma's (SILO) quarterly Divestments came in at $284456.0 in Q4 2021, up 113.96% quarter-over-quarter from $132951.0 in Q3 2019.
Powered by 
Analysis
Silo Pharma (SILO) Divestments (2019 - 2021) Analysis & Trends
Silo Pharma has disclosed Divestments across 2 years of filings, most recently posting $284456.0 for Q4 2021.
- In Q4 2021, Divestments changed N/A year-over-year to $284456.0; the TTM figure through Dec 2022 stood at $284456.0 (changed N/A YoY), while the FY2022 annual figure was $66707.0, down 99.05% from the prior year.
- Divestments came in at $284456.0 for Q4 2021 at Silo Pharma, up from $132951.0 in the prior quarter.
- In the past five years, Divestments ranged from a high of $284456.0 in Q4 2021 to a low of $132951.0 in Q3 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | - |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | - |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | - |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | - |
| 10 | Silo Pharma | 2.57 Mn | 2.57 Mn | - | - |